Fact CheckerSign in

NCT05322837Active, not recruiting

Tracking of Upper Limb Sensory and Motor Recovery in Asian Stroke Survivors

Deep Phenotyping of Upper Limb Sensori-motor Recovery in Asian Stroke Survivors: Concept, Development and Implementation of a Rehabilomics-driven Technology-assisted Data Platform

Source: ClinicalTrials.gov · Last updated 7 Oct 2026

Brief summary (registry, in English)

As Singapore's population is aging rapidly, the incidence rate of stroke has been increasing in the past years. Rehabilitation is essential for the resumption of daily activities, and with the appropriate care, it is possible for stroke-survivors to regain most of their functions. Hence, this study aims to better understand upper limb recovery covering different stages post-stroke in a representative cohort of Asian adults

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
107 (actual)
First submitted
1 Apr 2022
Start date
26 Apr 2023
Primary completion date
31 Dec 2027
Lead sponsor
Tan Tock Seng Hospital
Diseases
Stroke
NCT number
NCT05322837

What you commit to

  • Study type: Observational
  • Participants enrolled: 107
  • From 26 Apr 2023 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • End organ failures on replacements (renal dialysis or renal replacement therapies)

Other illness

  • Recurrent stroke or transient ischaemic attack (TIA)
  • Upper limb impairment not related to stroke: e.g., subarachnoid haemorrhage, traumatic brain injury or brain tumours
  • Bilateral upper limb impairment.
  • Uncontrolled medical conditions such as hypertension, hypotension, diabetes mellitus, unstable angina, cardiac failure or sepsis will be excluded.
  • Severe behavioural disturbance or agitation or epilepsy or untreated depression
  • Admission to rehab ward later than 8 weeks post-stroke
  • (For TMS assessments only) History of epilepsy or seizures, or cranial surgeries, or have metal implants in body or head, or have implanted electronics, or have metallic valve, or skull fracture or brain injury, or head or brain surgeries.

Other

  • Active fractures or arthritis of upper limb joints/bones
  • Visual Analogue Scale (VAS) pain \> 5/10
  • MOCA \< 21/30
  • Life expectancy \< 6 months
  • Minimally responsive or unresponsive awareness (vegetative) states
  • Pregnancy or lactation states

Who the study is looking for

  • Stroke confirmed by neurologists, neurosurgeons and brain imaging (CT, CT angiogram, MRI, MR angiogram)
  • First ever confirmed stroke
  • Asian ethnicity
  • Age 21-90 years
  • Montreal Cognitive Assessment (MOCA) scores 21/30 and above
  • Admission to rehabilitation ward is within 8 weeks of stroke onset

Age in the registry: 21 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tan Tock Seng Hospital
Coordinator of this site? Confirm its status
SingaporeSingaporeUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.